Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123026) titled 'Evaluation of the pharmacokinetic properties, safety, and tolerability of JKN2404 inhalation suspension in healthy Chinese subjects in a randomized, double-blind, placebo-controlled, dose-escalating Phase I clinical study' on April 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Hospital of Changsha
Condition:
Respiratory Diseases
Intervention:
Test group 1:Single Ascending Dose
Control group 1:Single Ascending Dose
Test group 2:Multiple Ascending Dose
Recruitment Status: Recruiting
Phase: 1
Date of First Enrollment: 2026-04-26
Target Sample Size: Test group 1:40...